- Home
- ABEO vs TDUP Comparison
ABEO vs TDUP Comparison
Compare ABEO & TDUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | TDUP |
|---|---|---|
| Founded | 1974 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.5M | 306.0M |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ABEO | TDUP |
|---|---|---|
| Price | $4.35 | $2.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $18.88 | $7.24 |
| AVG Volume (30 Days) | 1.0M | ★ 1.5M |
| Earning Date | 11-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | 75.36 |
| EPS | N/A | ★ N/A |
| Revenue | $2,998,000.00 | ★ $310,813,000.00 |
| Revenue This Year | $804.33 | $11.57 |
| Revenue Next Year | $119.68 | $10.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 258.18 | 19.53 |
| 52 Week Low | $4.00 | $1.91 |
| 52 Week High | $7.65 | $8.81 |
Technical Indicators
Market Signals| Indicator | ABEO | TDUP |
|---|---|---|
| Relative Strength Index (RSI) | 35.92 | 41.67 |
| Support Level | $4.27 | N/A |
| Resistance Level | $5.91 | $2.52 |
| Average True Range (ATR) | 0.23 | 0.17 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 10.83 | 28.64 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About TDUP ThredUp Inc.
ThredUp Inc is an online resale platform for apparel, shoes, and accessories. The company's marketplaces have enabled buyers in the United States ("U.S.") to browse and purchase resale items principally for apparel, shoes, and accessories across a range of price points. The company's revenue is principally from the sale of secondhand apparel, shoes, and accessories on behalf of sellers.